After adjustment for tumor grade and molecular subtype, a linearregression model with rank transformation showed that the DNA expression of 2genes (PALB2 and ERCC1) assessed in pre-NACTbiopsies was lower in the pCR group than in the non-pCR group (P=0.014 andP=0.040, respectively). The gene discussed is PALB2; the disease is neoplasm.